12 November - 13 November 2018
SCI's Fine Chemicals Group and RSC's Biological and Medicinal Chemistry Sector
This event is no longer available for registration.
Rising antimicrobial resistance is decreasing the efficacy of existing treatments for infection. With the alarming prospect of a post-antibiotic era, it is vital that we refresh the drug pipeline with new therapies and therapeutics that act through novel modes of action. With pressure from governments and increased public awareness of this growing problem, renewed interest from industry and academia has led to a resurgence in antimicrobial drug discovery, with the exciting prospect of new and innovative technologies and approaches for combating infection.
Following the first successful event in 2016, this meeting will examine the current state of the art in antimicrobial drug discovery from a medicinal chemist's perspective. Coinciding with World Antibiotics Awareness week, a two-day programme of speakers from industry and academia wil highlight the challenges associated with discovering and developing new antimicrobials, whilst also showcasing emerging strategies that are being developed to tackle infection.
|12:00||Registration, exhibition and lunch|
|13:10||Antibiotics: challenges and opportunities
Dr Stephen Baker, GlaxoSmithKline
|13:55||Rational and irrational discovery of novel interventions to treat drug-resistant infections
Prof Matt Cooper, University of Queensland and Inflazome
|14:40||Flash poster presentations|
|15:00||Refreshment break and exhibition|
|15:30||Towards photopharmacological antimicrobial chemotherapy
Dr Matthew Fuchter, Imperial College London
|16.00||SPARKing new antibiotic discovery
Wes Kim, The Pew Charitable Trusts
|16:30||Research and development of new antimicrobial drugs and combinations: a not-for-profit approach
Prof Laura Piddock, Global Antibiotic Research & Development Partnership
|17:15||Networking and refreshments|
Tuesday 13 November
|09:00||Rules for bacterial penetration - what we know and what we don't
Dr Paul Finn, Oxford Drug Design
|09:30||Reversing efflux-mediated resistance to reinvent broad-spectrum antibiotics
Dr K Miraz Rahman, King's College London
|10:00||Predictive guidelines for compound accumulation lead to new broad-spectrum antibiotics
Prof Paul Hergenrother, University of Illinois
|10:45||Refreshment break and exhibition|
|11:15||Non-hydroxamate LpxC inhibitors
Dr Alastair Parkes, Evotec
|11:45||Novel immunotherapeutics to target Gram-negative bacterial infections
Dr Emma Leire, Centauri Therapeutics
|12:15||Analysis of potassium (K+) efflux systems (Kef) as an antibiotic target in pathogenic bacteria
Catherine Haslam, University of Oxford
|12:30||Turning strength into a weakness: exploiting resistance as a novel therapeutic target
Lindsay Evans, Imperial College London
|12:45||MAPS: Multiparameter Assay for Profiling Susceptibility
Dr Lisa Miller, University of York
|13:00||Lunch and exhibition|
|14:00||Short antimicrobial peptides - their potential against multidrug resistant bacteria
Dr Kai Hilpert, St George's, University of London
|14:30||From HTS to preclinical candidate: a novel small-molecule antibiotic for the treatment of drug-resistant Neisseria gonorrhoeae
Dr Paul Meo, Summit Therapeutics
|15:00||Refreshment break and exhibition|
|15:30||Metallo β-lactamase inhibitors: an approach to combat the threat of emerging carbapenem resistance due to metallo β-lactamase enzymes in Gram-negative bacteria
Dr David Davies, AntaBio
|16:00||Challenges in antibacterial drug discovery
Prof Ian Gilbert, University of Dundee
14/15 Belgrave Square
Tel: +44 (0)20 7598 1561
Early bird fees before Friday 5 October 2018
|£150||SCI / RSC Member|
|£50||SCI / RSC Student Member|
|£100||SCI / RSC Subsidised Member|
|£180||One Nucleus Member|
Standard fees after Friday 5 October 2018
|£180||SCI / RSC Member|
|£60||SCI / RSC Student Member|
|£120||SCI / RSC Subsidised Member|
|£220||One Nucleus Member|
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
Early career researchers wishing to give a short talk (10 minutes) are encouraged to submit a one-page abstract to email@example.com by Friday 15 June 2018 with "AMR short talk abstract" in the subject line. Unsuccessful applicants will automatically be considered to present a poster.
Anyone wishing to present a poster should submit a one-page abstract to firstname.lastname@example.org by Friday 14 September 2018 with "AMR - poster abstract" in the subject line. Selected poster presenters will be given the opportunity to give a flash presentation.
A limited number of bursaries are available to SCI/RSC student members to cover their registration fees and contribute to their travel and accommodation costs. To apply for a bursary, please send an email to email@example.com by Friday 14 September 2018 with "AMR II - bursary application" in the subject line.
An exhibition will take place alongside the conference. Companies and related organisations who may wish to exhibit, please email firstname.lastname@example.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.
Become an SCI Member to receive benefits and discounts